Relief Therapeutics Holding AG

(OTC:RLFTF)

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Relief Therapeutics Holding AG is a Switzerland based drug development company focusing on clinical stage projects, primarily developing drugs of natural human origin. It is engaged in its operations for diabetic complications and respiratory diseases. The company is focused on developing drug candidates namely, Aviptadil and Atexakin alfa. Aviptadil is a biologically active endogenous human peptide that possesses anti-proliferative, anti-inflammatory, and immune regulatory activities. Atexakin alfa is a low dosage formulation of interleukin-6 that exhibits functions in diverse tissues and organs. The group operates its functions in Switzerland.

Contact Information

Website: www.relieftherapeutics.com
Main Phone: +41 447235959
Address: Avenue de Secheron 15
Address 2: Fondation EIP, Batiment Floor 2/Floor 3
City / Town: Geneva
Country: CH
Postal Code: CH-1202

Issuer Information

Exchange: OTCQB
Employees: 10

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A